View Clinical Trial (Medical Research Study)
Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis - NCT00570752-10029(Clinical Trial 194122)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
New York |
|
State:
|
|
NY |
| Zip Code: |
|
10029 |
| Conditions: |
|
Vascular Diseases |
| Purpose: |
|
The purpose of the study is to determine whether a p38 kinase inhibitor reduces inflammation
in atherosclerotic plaque
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- History of documented atherosclerosis
- LDL between 70 and 130 mg/dL
- Patients receiving stable low- to moderate-dose statin
- BMI 18-37 kg/m²
- Must be able to swallow tablets
- Must be able to medically tolerate the procedures, contrast medium, and medications
involved
Exclusion Criteria:
- Statin intolerance
- Renal impairment (serum creatinine > 1.5 mg/dL)
- History of chronic viral hepatitis or other liver dysfunction
- Major infection requiring hospitalization or receipt of IV antibiotics due to an
infection within 2 months prior to initiation of study treatment |
|
|
|
| Study is available at: |
|
Mount Sinai School Of Medicine Imaging Science Laboratories New York, NY 10029 United States
Primary Contact: For participation information at a USA site use a phone number below. For site information outside the USA please email: Email: Clinical.Trials@bms.com |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|